Israel Joseph

EVP Israel Joseph sold 38,000 DK shares at $40.65 (2 prior sales both well-timed); stock now down 5.6% from 52-week high after 30-day gain of +29.3%

Israel Joseph reduced his stake in Delek US Holdings by 40.6%, liquidating 38,000 shares at $40.65 for $1,544,700. His prior trades at DK consist of two separate sells on 2025-11-11 and 2025-11-12, both of which were well-timed at the 90-day mark (returning -16.8% and -16.4% respectively), suggesting a pattern of executing sales ahead of declines. The current transaction occurs with the stock up 29.3% over 30 days and up 16.2% over 90 days from prior lows, placing the sale at $40.65 near the 52-week high of $44.79 but still 5.6% below peak. Against this backdrop, the company reports elevated valuation (P/E of 111.29), annual revenue decline of 9.5%, and was unprofitable on a full-fiscal-year basis despite recent quarterly profitability of $178.0M on $2.9B revenue. The scale of the sale and its timing relative to recent price recovery warrant investor attention given the insider's demonstrated pattern of timing exits at market peaks.

EVP Israel Joseph sold 24,408 shares of Delek US (DK) for $1,002,777.18 in 2 transactions at blended avg $41.08, reducing stake 30.4% amid revenue decline of -29.9%

Israel Joseph, EVP at Delek US Holdings, executed 2 separate sales totaling 24,408 shares for $1,002,777.18, reducing his holdings from 80.2K to 55.8K shares (a -30.4% reduction). The sales occurred at a blended average price of $41.08, just below the 52-week high of $41.70. This divestiture is noteworthy against the company's deteriorating fundamentals: annual revenue growth stands at -29.9%, and the company reported negative full-year net income despite posting a quarterly profit of $178.0M. The stock itself has surged 80.9% over the past 90 days and is currently at $39.36, 5.6% below its 52-week peak. While Joseph's cross-ticker track record shows a 100% win rate on his 1 prior buy (avg 90-day return +2.4%), this sale of approximately one-third of his position occurs in an environment of significant revenue contraction and at price levels approaching his holdings' recent highs, suggesting a material reduction in direct equity exposure.

EVP Israel Joseph buys 3,076 shares at $39.00; cluster of 4 insider purchases in 14 days

Israel Joseph, EVP of Operations, purchased 3,076 shares at $39.00 on 2024-10-10, increasing his holdings by 28.7% from 10,706 to 13,782 shares for a total value of $119,964.00. This transaction is part of a cluster pattern, with 3 other insiders also buying within the past 14 days, suggesting coordinated or independently motivated accumulation at the current price level. The stock is currently trading at $39.14, near the transaction price, and stands 25.4% below its 52-week high of $52.48, providing context for the purchase decision. DKL trades at a P/E of 14.13 with annual revenue declining 1.5% year-over-year, indicating this purchase occurs in a period of modest operational contraction relative to fundamentals.